(Q45767577)

15 December 2017

title

Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection (English)

1 reference

15 December 2017

multicenter clinical trial

main subject

1 reference

A Mastrolorenzo

1

1 reference

15 December 2017

L Tiradritti

series ordinal

2

1 reference

15 December 2017

L Salimbeni

series ordinal

3

1 reference

15 December 2017

G Zuccati

series ordinal

4

1 reference

15 December 2017

language of work or name

1 reference

1 November 1995

1 reference

15 December 2017

International Journal of STD & AIDS

published in

1 reference

15 December 2017

volume

6

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

431-435

1 reference

15 December 2017

A virus-particle vaccine prepared from bovine mammillitis virus against herpes genitalis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Native HSV Glycoprotein D Subunit Vaccine: Analysis ofin VitroT-Cell Activation and Antigen Presentation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Systemic and mucosal cell mediated immune responses against herpes simplex virus in vaccinated guinea-pigs detected by lymphocyte proliferation and monoclonal antibodies against macrophages and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Antibody reactivity with Skinner HSV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646249500600611

10.1177/095646249500600611

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017